212 related articles for article (PubMed ID: 33593386)
1. The colorectal cancer-associated faecal microbiome of developing countries resembles that of developed countries.
Young C; Wood HM; Seshadri RA; Van Nang P; Vaccaro C; Melendez LC; Bose M; Van Doi M; Piñero TA; Valladares CT; Arguero J; Balaguer AF; Thompson KN; Yan Y; Huttenhower C; Quirke P
Genome Med; 2021 Feb; 13(1):27. PubMed ID: 33593386
[TBL] [Abstract][Full Text] [Related]
2. Microbiome Analysis of More Than 2,000 NHS Bowel Cancer Screening Programme Samples Shows the Potential to Improve Screening Accuracy.
Young C; Wood HM; Fuentes Balaguer A; Bottomley D; Gallop N; Wilkinson L; Benton SC; Brealey M; John C; Burtonwood C; Thompson KN; Yan Y; Barrett JH; Morris EJA; Huttenhower C; Quirke P
Clin Cancer Res; 2021 Apr; 27(8):2246-2254. PubMed ID: 33658300
[TBL] [Abstract][Full Text] [Related]
3. Examining the potential use and long-term stability of guaiac faecal occult blood test cards for microbial DNA 16S rRNA sequencing.
Taylor M; Wood HM; Halloran SP; Quirke P
J Clin Pathol; 2017 Jul; 70(7):600-606. PubMed ID: 28011577
[TBL] [Abstract][Full Text] [Related]
4. Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2009; 9(10):1-40. PubMed ID: 23074514
[TBL] [Abstract][Full Text] [Related]
5. Faecal immunochemical tests versus guaiac faecal occult blood tests: what clinicians and colorectal cancer screening programme organisers need to know.
Tinmouth J; Lansdorp-Vogelaar I; Allison JE
Gut; 2015 Aug; 64(8):1327-37. PubMed ID: 26041750
[TBL] [Abstract][Full Text] [Related]
6. Switching from guaiac to immunochemical faecal occult blood test increases participation and diagnostic yield of colorectal cancer screening.
Bretagne JF; Piette C; Cosson M; Durand G; Lièvre A
Dig Liver Dis; 2019 Oct; 51(10):1461-1469. PubMed ID: 31151896
[TBL] [Abstract][Full Text] [Related]
7. Effect of once-only flexible sigmoidoscopy screening on the outcomes of subsequent faecal occult blood test screening.
Brown JP; Wooldrage K; Kralj-Hans I; Wright S; Cross AJ; Atkin WS
J Med Screen; 2019 Mar; 26(1):11-18. PubMed ID: 30282520
[TBL] [Abstract][Full Text] [Related]
8. Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer.
Yu J; Feng Q; Wong SH; Zhang D; Liang QY; Qin Y; Tang L; Zhao H; Stenvang J; Li Y; Wang X; Xu X; Chen N; Wu WK; Al-Aama J; Nielsen HJ; Kiilerich P; Jensen BA; Yau TO; Lan Z; Jia H; Li J; Xiao L; Lam TY; Ng SC; Cheng AS; Wong VW; Chan FK; Xu X; Yang H; Madsen L; Datz C; Tilg H; Wang J; Brünner N; Kristiansen K; Arumugam M; Sung JJ; Wang J
Gut; 2017 Jan; 66(1):70-78. PubMed ID: 26408641
[TBL] [Abstract][Full Text] [Related]
9. Guaiac faecal occult blood test performance at initial and repeat screens in the English Bowel Cancer Screening Programme.
Kearns B; Whyte S; Chilcott J; Patnick J
Br J Cancer; 2014 Oct; 111(9):1734-41. PubMed ID: 25180767
[TBL] [Abstract][Full Text] [Related]
10. High test positivity and low positive predictive value for colorectal cancer of continued faecal occult blood test screening after negative colonoscopy.
Brown JP; Wooldrage K; Wright S; Nickerson C; Cross AJ; Atkin WS
J Med Screen; 2018 Jun; 25(2):70-75. PubMed ID: 28467146
[TBL] [Abstract][Full Text] [Related]
11. The gut microbiota in adults with cystic fibrosis compared to colorectal cancer.
Caley LR; Wood HM; Bottomley D; Fuentes Balaguer A; Wilkinson L; Dyson J; Young C; White H; Benton S; Brearley M; Quirke P; Peckham DG
J Cyst Fibros; 2024 Mar; 23(2):262-268. PubMed ID: 38104000
[TBL] [Abstract][Full Text] [Related]
12. Benefits of switching from guaiac-based faecal occult blood to faecal immunochemical testing: experience from the Wallonia-Brussels colorectal cancer screening programme.
Guo F; De Brabander I; Francart J; Candeur M; Polus M; Van Eycken L; Brenner H
Br J Cancer; 2020 Mar; 122(7):1109-1117. PubMed ID: 32066910
[TBL] [Abstract][Full Text] [Related]
13. Urinary volatile organic compounds and faecal microbiome profiles in colorectal cancer.
McFarlane M; Millard A; Hall H; Savage R; Constantinidou C; Arasaradnam R; Nwokolo C
Colorectal Dis; 2019 Nov; 21(11):1259-1269. PubMed ID: 31282600
[TBL] [Abstract][Full Text] [Related]
14. Using fecal immunochemical tubes for the analysis of the gut microbiome has the potential to improve colorectal cancer screening.
Krigul KL; Aasmets O; Lüll K; Org T; Org E
Sci Rep; 2021 Oct; 11(1):19603. PubMed ID: 34599256
[TBL] [Abstract][Full Text] [Related]
15. The oral microbiota in colorectal cancer is distinctive and predictive.
Flemer B; Warren RD; Barrett MP; Cisek K; Das A; Jeffery IB; Hurley E; O'Riordain M; Shanahan F; O'Toole PW
Gut; 2018 Aug; 67(8):1454-1463. PubMed ID: 28988196
[TBL] [Abstract][Full Text] [Related]
16. First steps towards combining faecal immunochemical testing with the gut microbiome in colorectal cancer screening.
Grobbee EJ; Lam SY; Fuhler GM; Blakaj B; Konstantinov SR; Bruno MJ; Peppelenbosch MP; Kuipers EJ; Spaander MC
United European Gastroenterol J; 2020 Apr; 8(3):293-302. PubMed ID: 32213018
[TBL] [Abstract][Full Text] [Related]
17. Faecal immunochemical tests to triage patients with lower abdominal symptoms for suspected colorectal cancer referrals in primary care: a systematic review and cost-effectiveness analysis.
Westwood M; Corro Ramos I; Lang S; Luyendijk M; Zaim R; Stirk L; Al M; Armstrong N; Kleijnen J
Health Technol Assess; 2017 May; 21(33):1-234. PubMed ID: 28643629
[TBL] [Abstract][Full Text] [Related]
18. Using gut microbiota as a diagnostic tool for colorectal cancer: machine learning techniques reveal promising results.
Lu F; Lei T; Zhou J; Liang H; Cui P; Zuo T; Ye L; Chen H; Huang J
J Med Microbiol; 2023 Jun; 72(6):. PubMed ID: 37288545
[No Abstract] [Full Text] [Related]
19. A comparative study of faecal occult blood kits in a colorectal cancer screening program in a cohort of healthy construction workers.
Shuhaibar M; Walsh C; Lindsay F; Lee N; Walsh P; O'Gorman P; Boran G; McLoughlin R; Qasim A; Breslin N; Ryan B; O'Connor H; O'Morain C
Ir J Med Sci; 2011 Mar; 180(1):103-8. PubMed ID: 20953981
[TBL] [Abstract][Full Text] [Related]
20. Collection of non-meconium stool on fecal occult blood cards is an effective method for fecal microbiota studies in infants.
Wong WSW; Clemency N; Klein E; Provenzano M; Iyer R; Niederhuber JE; Hourigan SK
Microbiome; 2017 Sep; 5(1):114. PubMed ID: 28870234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
